These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8246131)

  • 1. 3-Deazaadenosine: a therapeutic strategy for myasthenia gravis by decreasing the endocytosis of acetylcholine receptors.
    Kuncl RW; Drachman DB; Adams R; Lehar M
    J Pharmacol Exp Ther; 1993 Nov; 267(2):582-9. PubMed ID: 8246131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of myasthenic immunoglobulins and cholinergic agonists on acetylcholine receptors of rat myotubes.
    Ashizawa T; Elias SB; Appel SH
    Ann Neurol; 1982 Jan; 11(1):22-7. PubMed ID: 6277235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymyositis: reduction of acetylcholine receptors in skeletal muscle.
    Pestronk A; Drachman DB
    Muscle Nerve; 1985; 8(3):233-9. PubMed ID: 4058467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of myasthenia gravis antibodies to different acetylcholine receptor preparations.
    Zielinski A; Brenner T; Abramsky O
    Isr J Med Sci; 1982 Apr; 18(4):483-6. PubMed ID: 7085248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of junctional acetylcholine receptors in myasthenia gravis: clinical correlates.
    Pestronk A; Drachman DB; Self SG
    Muscle Nerve; 1985; 8(3):245-51. PubMed ID: 4058469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroids induce acetylcholine receptors on cultured human muscle: implications for myasthenia gravis.
    Kaplan I; Blakely BT; Pavlath GK; Travis M; Blau HM
    Proc Natl Acad Sci U S A; 1990 Oct; 87(20):8100-4. PubMed ID: 2236023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myasthenic patients' IgG causes redistribution of acetylcholine receptors: freeze-fracture studies.
    Pumplin DW; Drachman DB
    J Neurosci; 1983 Mar; 3(3):576-84. PubMed ID: 6827310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myasthenic antibodies cross-link acetylcholine receptors to accelerate degradation.
    Drachman DB; Angus CW; Adams RN; Michelson JD; Hoffman GJ
    N Engl J Med; 1978 May; 298(20):1116-22. PubMed ID: 643030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired slow-channel syndrome: a form of myasthenia gravis with prolonged open time of the acetylcholine receptor channel.
    Wintzen AR; Plomp JJ; Molenaar PC; van Dijk JG; van Kempen GT; Vos RM; Wokke JH; Vincent A
    Ann Neurol; 1998 Oct; 44(4):657-64. PubMed ID: 9778265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital canine myasthenia gravis: II. Acetylcholine receptor metabolism.
    Oda K; Lennon VA; Lambert EH; Palmer AC
    Muscle Nerve; 1984; 7(9):717-24. PubMed ID: 6543920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of myasthenia gravis by preventing acetylcholine receptor modulation.
    Losen M; Martínez-Martínez P; Phernambucq M; Schuurman J; Parren PW; De Baets MH
    Ann N Y Acad Sci; 2008; 1132():174-9. PubMed ID: 18567867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of myasthenic patients' immunoglobulin on acetylcholine receptor turnover: selectivity of degradation process.
    Drachman DB; Angus CW; Adams RN; Kao I
    Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3422-6. PubMed ID: 277944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetylcholine release in myasthenia gravis: regulation at single end-plate level.
    Plomp JJ; Van Kempen GT; De Baets MB; Graus YM; Kuks JB; Molenaar PC
    Ann Neurol; 1995 May; 37(5):627-36. PubMed ID: 7755358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of methyltransferase reduces the turnover of acetylcholine receptors.
    Kuncl RW; Drachman DB; Adams R
    Proc Natl Acad Sci U S A; 1988 Jun; 85(11):4032-6. PubMed ID: 3375253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myasthenia gravis and myasthenic syndrome: simulation of twitch strength with or without therapy.
    Nigrovic V; Amann A; Bhatt S
    Muscle Nerve; 2005 Dec; 32(6):745-50. PubMed ID: 16094654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen-specific apheresis of pathogenic autoantibodies from myasthenia gravis sera.
    Tzartos SJ; Bitzopoulou K; Gavra I; Kordas G; Jacobson L; Kostelidou K; Lagoumintzis G; Lazos O; Poulas K; Sideris S; Sotiriadis A; Trakas N; Zisimopoulou P
    Ann N Y Acad Sci; 2008; 1132():291-9. PubMed ID: 18567880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapsyn and agrin slow the metabolic degradation of the acetylcholine receptor.
    Phillips WD; Vladeta D; Han H; Noakes PG
    Mol Cell Neurosci; 1997; 10(1-2):16-26. PubMed ID: 9361285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of rapsyn in muscles prevents acetylcholine receptor loss in experimental autoimmune myasthenia gravis.
    Losen M; Stassen MH; Martínez-Martínez P; Machiels BM; Duimel H; Frederik P; Veldman H; Wokke JH; Spaans F; Vincent A; De Baets MH
    Brain; 2005 Oct; 128(Pt 10):2327-37. PubMed ID: 16150851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetylcholine in intercostal muscle from myasthenia gravis patients and in rat diaphragm after blockade of acetylcholine receptors.
    Molenaar PC; Polak RL; Miledi R; Alema S; Vincent A; Newsom-Davis J
    Prog Brain Res; 1979; 49():449-58. PubMed ID: 515442
    [No Abstract]   [Full Text] [Related]  

  • 20. Acquired canine myasthenia gravis: immunocytochemical localization of immune complexes at neuromuscular junctions.
    Pflugfelder CM; Cardinet GH; Lutz H; Holliday TA; Hansen RJ
    Muscle Nerve; 1981; 4(4):289-95. PubMed ID: 7019698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.